ORGO News and Press, Organogenesis Holdings Inc. From 09/28/23

2023-09-28 10:00:05 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) BofA Securities: Which small cap non-earner stocks to avoid Health Care Select Sector SPDR ETF declares quarterly distribution of $0.53...

CANTON, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, applauds ...

CANTON, Mass. , Sept. 06, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today ...

2023-08-10 13:34:30 ET More on Organogenesis Organogenesis Holdings, Inc. ( ORGO ) Q2 2023 Earnings Call Transcript Organogenesis: Solid Revenue Generation From A Hyper-Trading Wound Care Company Morgan Stanley starts Organogenesis at equal weight, cites reimburs...

2023-08-10 11:54:04 ET Shares of Organogenesis Holdings (NASDAQ: ORGO) were down more than 19% as of 11 a.m. on Thursday after the company announced second-quarter earnings and withdrew annual guidance after the markets closed on Wednesday. The stock is up less than 1% so far ...

2023-08-10 10:27:32 ET Gainers: LifeMD ( LFMD ) +20% . Precigen ( PGEN ) +19% . Repare Therapeutics ( RPTX ) +16% . Cosmos Health ( COSM ) +13% . GoodRx Holdings ( GDRX ) +13% . Losers: Galera Therapeutics ( GRTX ) -...

2023-08-10 08:25:22 ET Galera Therapeutics ( GRTX ) -82% . Origin Materials ( ORGN ) -57% after Q2 earning release . Organogenesis Holdings ( ORGO ) -32% after Q2 earning release . Renovaro Biosciences ( RENB ) -23% . Wolverine World...

2023-08-09 20:40:24 ET Organogenesis Holdings, Inc. (ORGO) Q2 2023 Earnings Conference Call August 09, 2023, 17:00 ET Company Participants Gary Gillheeney - President, CEO & Chair David Francisco - CFO Conference Call Participants Ryan Zimmerman - BTI...

2023-08-09 20:30:29 ET Image source: The Motley Fool. Organogenesis (NASDAQ: ORGO) Q2 2023 Earnings Call Aug 09, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis (ORGO) Q2 2023 Earnings Call Transcript

2023-08-09 16:12:17 ET Organogenesis Holdings press release ( NASDAQ: ORGO ): Q2 GAAP EPS of $0.04 beats by $0.01 . Revenue of $117.3M (-3.4% Y/Y) beats by $2.2M . Adjusted net income of $6.1 million for the second quarter of 2023, compared to an adjusted n...